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Abstract
Introduction: After testing the interventions for improving the prevalence of contraceptive use, very few studies
have measured the long-term effects thereafter the end of the implementation. This study aimed to measure Yam
Daabo interventions’ effects on contraceptive use in Burkina Faso at twelve months after completion of the
intervention.
Methods: Yam Daabo was a two-group, multi-intervention, single-blind, cluster randomized controlled trial.
Interventions comprised refresher training for the provider, a counseling tool, supportive supervision, availability of
contraceptive services 7 days a week, client appointment cards, and invitation letters for partners. We used
generalized linear mixed-effects models (log Poisson) to compare the modern contraceptive prevalence at 12
months post-intervention in the two groups. We collected data between September and November 2018. We
conducted an intention-to-treat analysis and adjusted the prevalence ratios on cluster effects and unbalanced
baseline characteristics.
Results: Twelve months after the completion of the Yam Daabo trial, we interviewed 87.4% (485 out of 555
women with available data at 12 months, that is, 247/276 in the intervention group (89.5%) and 238/279 in the
control group (85.3%). No difference was observed in the use of hormonal contraceptive methods between the
intervention and control groups (adjusted prevalence ratio = 1.21; 95% confidence interval [CI] = [0.91–1.61], p =
0.191). By contrast, women in the intervention group were more likely to use long-acting reversible contraceptives
(LARC) than those in the control group (adjusted prevalence ratio = 1.35; 95% CI = [1.08–1.69], p = 0.008).
Conclusion: Twelve months after completion of the intervention, we found no significant difference in hormonal
contraceptive use between women in the intervention and their control group counterparts. However, women in
the intervention group were significantly more likely to use long-acting reversible contraceptives than those in the
control group.
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Introduction
Literature shows that several interventions have been
tested to improve the prevalence of contraceptive use [1,
2]. In 2015, we tested a package of interventions in two
African countries, Burkina Faso and the Democratic Re-
public of the Congo, in a randomized cluster trial design
called Yam Daabo [3, 4]. The postpartum family plan-
ning interventions package had two types of interven-
tions. The first one comprised three facility-oriented
interventions: refresher training of service providers,
regularly scheduled and strengthened supportive super-
vision of providers, enhanced availability of services 7
days a week. The second had three individual-based in-
terventions: a postpartum family planning counseling
tool, appointment cards for women, and invitation let-
ters for partners. The conception of the new counseling
tool takes into account all new World Health
Organization (WHO) recommendations on family plan-
ning service provision. The package was designed
through participatory action research, and the process
and contents are detailed elsewhere [4]. After 12 months
of follow-up (which marks the end of the interventions),
the main results showed a significant increase in the use
of appropriate modern contraceptive methods among
women receiving the interventions compared to women
not receiving the interventions. In Burkina Faso, at 12
months, the modern contraceptive prevalence rate was
55% among women in the intervention group and 29%
among women in the control group (adjusted prevalence
ratio: 1.79, 95% CI = 1.30–2.47) [5]. In the Democratic
Republic of the Congo, at 12 months, 46% of the women
in the intervention group and 35% of the women in the
control group were using modern contraceptives (ad-
justed prevalence ratio: 1.58, 95% CI = 0.74–3.38), with
significant differences in the use of contraceptive im-
plants (22% vs. 6%; adjusted prevalence ratio: 4.36, 95%
CI = 1.96–9.70) [6].
However, many questions remain unanswered a few
months after these types of interventions because most
studies examine the effects of interventions immediately
after the interventions’ completion. So, very few studies
have measured the long-term effects of the interventions
that were effective after they were discontinued.
As three (out of six) of Yam Daabo’s interventions
were individual-based, we hypothesized that (i) health
workers could continue to offer some elements of the
intervention package to women visiting the health cen-
ters, (ii) the effects may persist even after the
interventions were stopped since women could continue
to receive counseling during and after the first year post-
partum, (iii) women in the intervention group not using
the methods at the end of the interventions because of
past and current exposures could start using contracep-
tive methods one year after giving birth. We hypothesize
that appropriate contraceptive methods use would re-
main high at 12 months post-intervention among
women in the intervention group compared to those in
the control group. Therefore, this study aimed to meas-
ure the effects of the Yam Daabo trial interventions on
contraceptive methods use in Burkina Faso, 12 months
after the end of the interventions.
Methods
We conducted an evaluation of the Yam Daabo trial’s ef-
fects at twelve months after intervention completion.
The intervention was implemented in the Yako health
district (Centre-North region, Burkina Faso) between
July 27, 2016 and February, 28, 2018.
Burkina Faso is a sub-Saharan African country, with
an estimated population of 20,321,000 in 2019 [7]. Ac-
cording to Blumenberg et al., the modern contraceptive
prevalence rate was 31.9% in December 2018, based on
the analysis of Performance Monitoring and Account-
ability 2020 (PMA2020) data [8]. Ahmed et al., using the
Family planning 2020 data, reported an estimated unmet
need for modern contraception of 27.2% in 2017 [9]. As
in most countries in sub-Saharan Africa, cultural norms
favor large families, with higher fertility rates in rural
areas than in urban areas. In 2019, Burkina Faso had 5.6
live births per woman [7].
Description of the yam Daabo trial
The Yam Daabo intervention was a complex, multicen-
tre, randomized cluster trial implemented in two coun-
tries, Burkina Faso and the Democratic Republic of the
Congo. Methodological details on the Yam Daabo are
available in the published protocol [3]. We randomized
each country’s health centers into two groups during the
intervention phase: intervention and control. The health
centers in the experimental group offered six postpar-
tum family planning interventions that were identified as
solutions to the barriers identified during the formative
phase of the project and are already described in another
article [4]. The health centers in the control group of-
fered the usual postpartum family planning care. We in-
cluded and followed women at the third trimester of
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their pregnancy over 12 months after delivery. As said
above, Yam Daabo’s interventions comprised refresher
training for the provider, counseling tool, supportive
supervision, availability of contraceptive services 7 days a
week, client appointment cards, and invitation letters for
partners. Participants received individual-based interven-
tions during their pregnancy and during the postpartum
period, according to national practice (typically on clin-
ical discharge [24–48 h], at 6 days, 6 weeks, then at
months 6 and 9, before the trial exit at month 12 post-
partum). All pregnant women were eligible to participate
in the study if (1) they were in their third pregnancy tri-
mester; (2) the status of the pregnancy and the woman
allowed for a birth at the health center; (3) the woman
had the intention to attend antenatal care, delivery, and
postnatal care at the health center; (4) the woman did
not participate in another study; and (5) we obtained in-
formed consent. Research assistants collected data on
paper-based case report forms. The WHO team in Gen-
eva developed the case report forms with inputs from
the country’s research teams. Each health center of the
cluster randomized controlled trial had a research assist-
ant who was trained to adhere to the study manual and
standard operating procedures for data management,
which are common to both study countries and have
been developed by WHO. In each country, the eight
sites were matched by pairs according (1) the average
number of deliveries per month, (2) the ratio of health
workers per population, and (3) the settings (rural,
urban). Within each pair, we randomly selected the site
assigned to the experimental intervention. This
randomization was done four times. No restriction in
the randomization process was required. All consecutive
and eligible participants were included in the clusters.
Due to the nature of the interventions, participants,
health staff, research assistants assigned to each centre,
and the rest of the research team members could not be
masked to the cluster assignments.
The trial was approved by the WHO Ethics Commit-
tee and the Health Research Ethics Committee of Bur-
kina Faso and has been registered in the Pan-African
Clinical Trials Registry (registration number: PACT
R201609001784334 on 27/09/2016).
No interim analysis was conducted during this study.
At the end of the 12-month follow-up, analyses on
contraceptive use at each of the contact points (day 6,
week 6, month 6, and month 12) were conducted. These
results for Burkina Faso and the Democratic Republic of
the Congo have already been published [5, 6].
Type of study
We conducted a randomized, clustered, controlled trial
extending the follow-up of women to 12months post-
intervention.
Population
Our study population was all women who completed
Yam Daabo trial in Burkina Faso at 12 months and those
who were not found because of travel. We included
women lost to follow-up at 12 months because they were
all exposed to the interventions during pregnancy, deliv-
ery, and the postpartum period.
However, we did not include in this study women who
were pregnant at the 12th month, those who withdrew
from the study and finally women who died before the
12th month.
Additional collection period
We collected data from September 15, 2018, to Novem-
ber 15, 2018.
Key measures
The primary outcome of this study was the contracep-
tive method use. We used the classification adopted by
the WHO in 2015 [10]. Thus, for this analysis, the
groups of methods were defined as follows:
– Long-acting reversible contraceptive, including
implants and intrauterine devices
– Short-acting contraceptive methods, including
injectables, pills, emergency contraception, male and
female condoms
– Permanent methods (male and female sterilization)
– The lactational amenorrhea method
Next, we also classified the contraceptive methods into
“modern and appropriate methods” and “non-modern or
inappropriate methods.” The non-modern methods com-
prised traditional methods, withdrawal, and abstinence.
Inappropriate methods include lactational amenorrhea (if
used after 6months) and calendar-based methods (if used
during the first 12months postpartum).
The main independent variable was exposure to inter-
ventions, defined as the binary variable (coded 1 for the
intervention group and 0 for the control group).
Moreover, we measured the frequency of pregnancies
in both groups of women.
Data collection at 12months post-intervention
Five interviewers collected the data (They were part of
the interviewing team that collected follow-up data up
to 12 months postpartum). To locate the target partici-
pants, they used the women’s identification documents,
which contained their telephone numbers. Maternity
health workers and community-based health workers
provided valuable assistance in the search for women.
They conducted interviews mainly in health centers and
women’s homes or other secure public places chosen by
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the woman beforehand. Data on contraception use were
extracted into the health centers registers.
However, the 12-months post-intervention study was
conducted only in Burkina Faso not in the Democratic
Republic of the Congo. This data collection was decided
by the Burkina research team to measure family plan-
ning use after the interventions had ended.
Data processing and statistical analysis
EpiData and Stata 15.1 software were used for data entry
and analysis, respectively. To ensure the comparability
of results with published data on intervention effective-
ness at 12 months postpartum, we used generalized lin-
ear mixed-effects (log Poisson) models were used to
measure the effects of interventions on contraceptive
use with a significance threshold of 5%. We adjusted the
measure of association on sociodemographic variables
unequally distributed between the intervention and con-
trol groups, at inclusion. We also corrected for a pos-
sible cluster effect by taking into account any correlation
that might exist.
We followed Consolidated Standards of Reporting Tri-
als extension for pragmatic trials guidelines to write the
manuscript (supplementary file 1).
Results
Twelve months after the end of the Yam Daabo inter-
ventions, we interviewed 485 (87.4%) of 555 women
(those with available data at 12 months or lost to follow-
up). The lost to follow-up rates were 10.5% in the inter-
vention group (247 of 276 women included) and 14.7%
in the control group (238 of 279 women included). The
flow diagram, presented in Fig. 1, summarizes this infor-
mation. However, no statistical difference was observed
Fig. 1 Flow diagram
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in the lost to follow-up rates between the two groups
(p = 0.1362).
The chi-square test comparing women’s sociodemo-
graphic and gynecological characteristics at baseline
showed no significant difference in any of the variables
except the total number of abortions (p = 0.01). These
data are presented in Table 1.
Results showed no difference in modern contraceptive
use between the intervention and control groups at 12
months post-intervention (58.0% vs. 47.4%; Adjusted
prevalence ratio = 1.21; 95% CI = 0.91–1.61, p = 0.191).
The use of long-acting reversible contraceptives was
higher among women in the intervention group than in
those in the control group with a statistically significant
difference (37.4% vs. 27.5%; Adjusted prevalence ratio =
1.35; 95% CI = 1.08–1.69, p = 0.007). No significant dif-
ference was noted in the use of short-acting methods
(20.6% vs. 19.8%; Adjusted prevalence ratio = 1.00, 95%
CI = 0.55–1.81, p = 0.992). Among the non-modern or
inappropriate methods, only one woman was using the
standard days’ method. None of the women used a per-
manent method (vasectomy or tubal ligation) at 12
months post-intervention. Table 2 expressed these
results.
Concerning the frequency of pregnancies, we noted no
significant difference between women in the intervention
and control groups (21 out of 238 pregnant women in
the intervention group versus 23 out of 247 in the con-
trol group, 8.8 and 9.3%, respectively).
Discussion
This analysis has two main findings. First, Yam Daabo
trial interventions’ effects on modern family planning
use persisted 12months after the interventions ended,
but no statistically significant difference was noted be-
tween the experimental and control groups. Second, a
statistically significant difference was noted in its effects
on long-acting reversible contraceptives use.
Some authors, including Tu et al. [11], Speizer et al.
[12, 13], Subramanian et al. [14], and Jejeebhoy et al.
[15], after evaluating the long-term effects of certain in-
terventions related to contraceptives’ provision several
months after the cessation of interventions noted that
the effects varied in terms of the magnitude. Indeed, in
Shanghai, Tu et al. noted a significant difference in
contraceptive method use and reported a higher contra-
ceptive use in the group of young people who benefited
from the interventions 28 months after the cessation of
interventions [11]. Subramanian et al. [14] and Jejeebhoy
et al. [15] reported the persistence of effects 4 to 8 years
after the end of the Pathfinder International’s Promoting
Change in Reproductive Behavior project, implemented
between 2001 and 2012 in Bihar (India), on contracep-
tive use among young married couples. Speizer et al.
Table 1 Baseline characteristics of women who were
interviewed at 12 months post-intervention
Intervention n = 238
n(%)
Control n = 247
n(%)
Women’s age
Under 20 31 (13.0) 46 (18.6)
20–29 123 (51.7) 133 (53.8)
30 and more 84 (35.3) 68 (27.5)
Number of pregnancies
None 36 (15.1) 47 (19.0)
1–3 106 (44.5) 123 (49.8)
4–6 77 (32.4) 63 (25.5)
≥ 7 19 (8.0) 14 (5.7)
Number of living children
None 42 (17.6) 53 (21.5)
1–3 121 (50.8) 131 (53.0)
≥ 4 75 (31.5) 63 (25.5)
Number of previous live births
None 42 (17.6) 49 (19.8)
1–3 112 (47.1) 126 (51.0)
≥ 4 84 (35.3) 72 (29.1)
Number of stillbirths
None 224 (94.1) 222 (89.9)
≥ 1 stillbirth 14 (5.9) 25 (10.1)
Number of abortion*
None 206 (86.6) 231 (93.5)
≥ 1 abortion 32 (13.4) 16 (6.5)
Education status
No education 163 (68.5) 174 (70.4)
Primary school 35 (14.7) 36 (14.6)
Secondary/Tertiary 40 (16.8) 37 (15.0)
Marital status
Not in union 2 (0.8) 4 (1.6)
In union 236 (99.2) 243 (98.4)
Occupation
No occupation 1 (0.4) 0 (0.0)
Student 24 (10.1) 19 (7.7)
Housewife/Farmer 185 (77.7) 201 (81.4)
Salaried employee 2 (0.8) 5 (2.0)
Tradeswoman 26 (10.9) 22 (8.9)
Family planning use prior to the trial
No 161 (67.6) 178 (72.1)
Yes 77 (32.4) 69 (27.9)
Current pregnancy planned
Yes 115 (48.3) 113 (45.7)
No 123 (51.7) 134 (54.3)
*: significant difference (p = 0,01)
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noted the persistent effects of a community-based pro-
gram on contraceptive use in two cities where the pro-
gram had been implemented [12] and a change in the
effects of the same program on the quality of family
planning services after the program ended [13]. The in-
terventions’ nature can explain the durability of Yam
Daabo interventions effects (significant difference in the
use of long-acting reversible contraceptives) with three
individual-based rather than community-based. One
could be led to believe that the skills women learned
during the implementation phase of the interventions
guided them for 12months after the interventions’ com-
pletion. This is a cause for satisfaction because the cessa-
tion of the interventions coincided with the end of
repeated contact period between postpartum women
and health workers. In Burkina Faso’s context, these
contacts are limited to 12months postpartum.
The non-significant difference at 24-month in modern
contraceptive use between the experimental and control
groups could be explained by the effects of two cam-
paigns of free contraceptive methods’ distribution since
the last follow-up. These two campaigns were conducted
in all public health facilities (7 days each, including one
campaign in November and another one in June each
year). Compared with the results published at 12
months, this non-significant difference in the modern
contraceptive prevalence can be explained by the in-
creased contraceptive use in the control group (29% at
12 months [5] vs. 47.4% at 24 months). This net increase
in the control group could be related to the effects of
the national family planning week, which is celebrated
every June and November and covers all regions of Bur-
kina Faso, during which contraceptives are provided free
of charge. Such a campaign for free contraceptive
methods could therefore have more effect in the control
group (which included women who used the methods
less) than in the intervention group since there was a
55% use rate at 12 months [5]. It could be argued that
because of the higher proportion of unmet needs in the
control group, it is easier to register new users as soon
as free distribution campaigns take place. Current data
on the modern contraceptive prevalence in the general
population could help us better comprehend this rate’s
evolution in the control group. Thus, if contraceptive
methods were free, women would use more modern
methods. In the Burkinabe context, the implementation
of the interventions tested in this study, combined with
the free distribution of contraceptive products (already
ongoing in Burkina Faso since 2019 in some regions and
since 2020 throughout the country), could allow the
widespread use of modern contraceptive methods.
Our study had several limitations. First, the proportion
of people who were lost to follow-up was slightly high.
However, this did not affect our results’ internal validity
in terms of power since the initial hypothesis was that
60 women per health center, 480 women in total, should
be included to achieve the minimum desired power [3].
However, we selected and surveyed 485 women. Another
limitation was that we had no contact with the women
12months after the study. As a result, the participants
may have forgotten several episodes.
Conclusion
This study showed that the effects of interventions in
improving contraceptive use can be sustained for up to
12months after the interventions are completed. Indeed,
women continued to use appropriate contraceptive
methods and long-acting reversible contraceptives 12
months after the interventions were discontinued. The
modern contraceptive prevalence level of the interven-
tion group may have important implications in Burkina
Faso. Indeed, if Yam Daabo’s realistic interventions are
implemented and combined with free contraceptive
methods, nearly 3 out of 5 women will still be using
modern contraceptive methods at 24 months. This result
is more significant as contraceptive methods have been
provided free of charge in Burkina Faso’s public health
facilities since 2020.
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p Adjusted prevalence ratio (95%CI)a
Modern and appropriate methods 138/238 (58.0%) 117/247 (47.4%) 0.191 1.21 (0.91–1.61)
Long-acting methods 89/238 (37.4%) 68/247 (27.5%) 0.007 1.35 (1.08–1.69)
Short-acting methods 49/238 (20.6%) 49/247 (19.8%) 0.992 1.00 (0.55–1.81)
Non-modern or non-appropriate methods 1/238 (0.4%) 0/247 (0%) – –
No contraceptive method 100/238 (42%) 130/247 (53%) 0.224 0.8 (0.56–1.15)
a: adjusted results on the number of abortions
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